JP2009519212A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009519212A5 JP2009519212A5 JP2008537892A JP2008537892A JP2009519212A5 JP 2009519212 A5 JP2009519212 A5 JP 2009519212A5 JP 2008537892 A JP2008537892 A JP 2008537892A JP 2008537892 A JP2008537892 A JP 2008537892A JP 2009519212 A5 JP2009519212 A5 JP 2009519212A5
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- ome
- hsdavfteqy
- seq
- peg20k
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73029105P | 2005-10-26 | 2005-10-26 | |
| US74034205P | 2005-11-29 | 2005-11-29 | |
| US74336406P | 2006-02-28 | 2006-02-28 | |
| PCT/US2006/041550 WO2007050651A1 (en) | 2005-10-26 | 2006-10-24 | Selective vpac2 receptor peptide agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009519212A JP2009519212A (ja) | 2009-05-14 |
| JP2009519212A5 true JP2009519212A5 (https=) | 2009-12-17 |
Family
ID=37716005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008537892A Pending JP2009519212A (ja) | 2005-10-26 | 2006-10-24 | 選択的ｖｐａｃ２受容体ペプチドアゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7582608B2 (https=) |
| EP (1) | EP1942941A1 (https=) |
| JP (1) | JP2009519212A (https=) |
| KR (1) | KR101057284B1 (https=) |
| CN (1) | CN101296708B (https=) |
| AU (1) | AU2006306236B2 (https=) |
| BR (1) | BRPI0617740A2 (https=) |
| CA (1) | CA2627716A1 (https=) |
| EA (1) | EA012930B1 (https=) |
| IL (1) | IL189922A0 (https=) |
| NO (1) | NO20082345L (https=) |
| WO (1) | WO2007050651A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10328316A1 (de) | 2003-06-23 | 2005-01-20 | Grünenthal GmbH | Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe |
| EP1781692A2 (en) * | 2004-08-18 | 2007-05-09 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| US7595294B2 (en) * | 2004-10-08 | 2009-09-29 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
| US20090170775A1 (en) * | 2004-10-08 | 2009-07-02 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide compositions |
| DE102005052588A1 (de) * | 2005-11-02 | 2007-05-10 | Grünenthal GmbH | Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse |
| US20130172274A1 (en) | 2005-12-20 | 2013-07-04 | Duke University | Methods and compositions for delivering active agents with enhanced pharmacological properties |
| TWI496762B (zh) | 2006-07-24 | 2015-08-21 | 製備（１ｒ，２ｒ）-３-（３-二甲胺基-１-乙基-２-甲基-丙基）-酚之方法 | |
| CN102131516B (zh) | 2008-06-27 | 2016-03-16 | 杜克大学 | 包含弹性蛋白样肽的治疗剂 |
| US9029505B2 (en) * | 2009-08-14 | 2015-05-12 | Phasebio Pharmaceuticals, Inc. | Modified vasoactive intestinal peptides |
| MX2012006877A (es) | 2009-12-18 | 2012-08-31 | Idenix Pharmaceuticals Inc | Inhibidores de virus de hepatitis c de arileno o heteroarileno 5, 5 - fusionado. |
| CA2873553C (en) | 2011-06-06 | 2020-01-28 | Phasebio Pharmaceuticals, Inc. | Use of modified vasoactive intestinal peptides in the treatment of hypertension |
| US11052132B2 (en) | 2014-05-08 | 2021-07-06 | Phasebio Pharmaceuticals, Inc. | Methods and compositions for treating cystic fibrosis |
| CN114652817B (zh) | 2015-02-09 | 2026-04-17 | 费斯生物制药公司 | 用于治疗肌肉疾病和病症的方法和组合物 |
| JP7698318B2 (ja) * | 2020-03-30 | 2025-06-25 | 一丸ファルコス株式会社 | Ｖｉｐｒ２アンタゴニストペプチド |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04193896A (ja) * | 1989-10-26 | 1992-07-13 | Meiji Seika Kaisha Ltd | 活性ペプチド |
| JPH0692991A (ja) | 1991-02-28 | 1994-04-05 | Daicel Chem Ind Ltd | 新規活性ペプチド |
| WO1998002453A2 (en) | 1996-07-15 | 1998-01-22 | Universite Libre De Bruxelles | Peptidic ligands having a higher selectivity for the vip1 receptor than for the vip2 receptor |
| PL345583A1 (en) | 1998-07-20 | 2001-12-17 | Sod Conseils Rech Applic | Peptide analogues of pacap |
| US6242563B1 (en) | 1998-07-20 | 2001-06-05 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Peptide analogues |
| US20030087820A1 (en) * | 1999-01-14 | 2003-05-08 | Young Andrew A. | Novel exendin agonist formulations and methods of administration thereof |
| CA2372214A1 (en) | 1999-04-30 | 2000-11-09 | Amylin Pharmaceuticals, Inc. | Modified exendins and exendin agonists |
| CA2379604A1 (en) | 1999-09-28 | 2001-04-05 | Bayer Corporation | Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| AU2003200839B2 (en) | 2002-01-08 | 2008-12-11 | Eli Lilly And Company | Extended glucagon-like peptide-1 analogs |
| PL377025A1 (pl) | 2002-07-12 | 2006-01-23 | Bayer Pharmaceuticals Corporation | Agoniści receptora peptydu aktywującego przysadkową cyklazę adenylową (PACAP) -VPAC2 i ich farmakologiczne sposoby zastosowania |
| JP2006520818A (ja) * | 2003-03-19 | 2006-09-14 | イーライ リリー アンド カンパニー | ポリエチレングリコール結合ｇｌｐ−１化合物 |
| ATE461217T1 (de) | 2003-12-18 | 2010-04-15 | Novo Nordisk As | Glp-1-verbindungen |
| KR20070009554A (ko) * | 2004-01-27 | 2007-01-18 | 바이엘 파마슈티칼스 코포레이션 | 뇌하수체 아데닐레이트 사이클라제 활성화 펩티드(ｐａｃａｐ) 수용체 (ｖｐａｃ２) 작용제 및 이의약리학적 사용 방법 |
| ES2302201T3 (es) * | 2004-05-21 | 2008-07-01 | Eli Lilly And Company | Agonistas peptidicos del receptor vpac2 selectivos. |
| WO2005113594A1 (en) * | 2004-05-21 | 2005-12-01 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| EP1781692A2 (en) * | 2004-08-18 | 2007-05-09 | Eli Lilly And Company | Selective vpac2 receptor peptide agonists |
| BRPI0516126A (pt) | 2004-10-08 | 2008-08-26 | Forbes Medi Tech Res Inc | produtos farmacêuticos de polipeptìdeos intestinais vasoativos |
| WO2008043102A2 (en) | 2006-10-06 | 2008-04-10 | Transition Therapeutics Inc. | Vasoactive intestinal polypeptide compositions |
| US7595294B2 (en) | 2004-10-08 | 2009-09-29 | Transition Therapeutics, Inc. | Vasoactive intestinal polypeptide pharmaceuticals |
-
2006
- 2006-10-24 CN CN2006800398953A patent/CN101296708B/zh not_active Expired - Fee Related
- 2006-10-24 EP EP06817361A patent/EP1942941A1/en not_active Withdrawn
- 2006-10-24 WO PCT/US2006/041550 patent/WO2007050651A1/en not_active Ceased
- 2006-10-24 CA CA002627716A patent/CA2627716A1/en not_active Abandoned
- 2006-10-24 US US12/090,656 patent/US7582608B2/en not_active Expired - Fee Related
- 2006-10-24 KR KR1020087010055A patent/KR101057284B1/ko not_active Expired - Fee Related
- 2006-10-24 BR BRPI0617740-9A patent/BRPI0617740A2/pt not_active IP Right Cessation
- 2006-10-24 EA EA200801180A patent/EA012930B1/ru not_active IP Right Cessation
- 2006-10-24 JP JP2008537892A patent/JP2009519212A/ja active Pending
- 2006-10-24 AU AU2006306236A patent/AU2006306236B2/en not_active Expired - Fee Related
-
2008
- 2008-03-04 IL IL189922A patent/IL189922A0/en unknown
- 2008-05-23 NO NO20082345A patent/NO20082345L/no not_active Application Discontinuation
-
2009
- 2009-07-24 US US12/508,584 patent/US7897573B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009519212A5 (https=) | ||
| CN110229216B (zh) | 具有改善的药代动力学性质的坎普他汀类肽 | |
| DK2424557T3 (en) | MODIFIED COMPSTATIN WITH PEPTID BACKBONE AND C-TERMINAL MODIFICATIONS | |
| KR102812908B1 (ko) | 인크레틴 유사체의 제조 방법 | |
| EP2331567A1 (en) | Peptidomimetic macrocycles | |
| CN102171243A (zh) | N-端修饰的葡萄糖依赖性促胰岛素多肽(gip)类似物 | |
| CN115925790A (zh) | 用于合成α4β7肽拮抗剂的方法 | |
| JP2006525288A5 (https=) | ||
| WO2017023933A2 (en) | Peptidomimetic macrocycles | |
| KR20110097807A (ko) | 뉴로펩티드-2-수용체(ｙ-2ｒ) 작용제 및 이의 용도 | |
| JP2023551122A5 (https=) | ||
| CN101437836B (zh) | 肽的硫酯化合物的制造方法 | |
| JP2005516996A5 (https=) | ||
| AU2006306236B2 (en) | Selective VPAC2 receptor peptide agonists | |
| CN109134610B (zh) | 一种肽类化合物、其应用及含其的组合物 | |
| CA2584805C (en) | Peptide anti-tumor agent | |
| EP1915393A1 (en) | Selective vpac2 receptor peptide agonists | |
| CN114539358B (zh) | 一种多肽及制备方法与应用 | |
| WO2026009243A1 (en) | An improved process for the preparation of tirzepatide by using hybrid approach | |
| WO2025052429A1 (en) | An improved process for the preparation of tirzepatide | |
| HK40112064A (zh) | Crf2受体激动剂及其在治疗中的用途 | |
| HU211694A9 (en) | Hexapeptides with sulphate ester groups | |
| Human | iolo ical e affilation of ne ar inine ao re in P analo e containin non nat ral a ino acid | |
| WO1992019644A1 (fr) | Peptide vasodilatateur | |
| WO1998043995A1 (en) | Novel anti-hiv complexes and medicinal compositions |